Heart stent clogging again? new study tests best fix
NCT ID NCT04862052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 108 people whose heart stents had narrowed again after being placed. Doctors tested three different devices: two types of drug-coated balloons and one new stent. The goal was to see which one works best to keep the artery open and prevent future heart problems. The results could help doctors choose the best treatment for this common issue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
drug-coated balloons (sirolimus or paclitaxel) and drug-eluting stents (everolimus)
What this could lead to
If one treatment proves clearly better, it could become the new standard for managing stent re-narrowing, reducing repeat procedures and heart attacks.
What could go wrong
This is a small, completed study (108 patients) with no blinding. Results may not apply to all patients, and differences between treatments might be small or due to chance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY STENT RESTENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Semmelweis University Heart and Vascular Center
Budapest, Budapest, 1122, Hungary
-
University of Szeged, Department of Invasive Cardiology
Szeged, Csongád-Csanád, 6725, Hungary